Esperion Therapeutics, Inc. (0IIM.L) LSE
2.58
-0.065(-2.46%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.58
-0.065(-2.46%)
Currency In USD
| Market Cap | 769.1M |
| Enterprise Value | 1.15B |
| P/E Ratio | -27.23 |
| PEG Ratio | -0.37 |
| Price/Sales Ratio | 1.35 |
| Price/Book Ratio | -2.05 |
| Enterprise/Revenue | 2.29 |
| Enterprise/EBITDA | 14.7 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.06 |
| Operating Margin | 0.15 |
| Return On Assets | -0.05 |
| Return On Equity | 0.06 |
| Revenue | 403.14M |
| Revenue/Share | 1.7 |
| Gross Profit | 273.91M |
| EBITDA | 60.27M |
| Net Income | -22.68M |
| Diluted EPS | -0.11 |
| Total Cash | 167.85M |
| Total Cash/Share | 0.71 |
| Total Debt | 548M |
| Total Debt/Equity | -1.81 |
| Current Ratio | 0.56 |
| Book Value Per Share | -1.28 |
| 52-Week Change | 95.08 |
| 52-Week High | 3.32 |
| 52-Week Low | 0.71 |
| Moving Average 50 Days | 2.51 |
| Moving Average 200 Days | 1.67 |
| Average Volume | 26,659 |
| Shares Outstanding | 207.91M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |